TWIST1 and neoplasm: At the cellular level, butein triggers miR-186-5p-induced modulation of TWIST1 expression, thereby inhibiting the growth of tumor spheroids, cell invasion, bioenergetics, and cisplatin resistance in the three PM cell lines [87].